default author photo

Chandramani Singh

All India Institute of Medical Sciences (AIIMS), Bhopal

Bhopal

India

  • All India Institute of Medical Sciences (AIIMS), Bhopal

SCHOLARLY PAPERS

3

DOWNLOADS

1,729

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Immunogenicity and Tolerability of BBV154 (iNCOVACC®), an Intranasal SARS-CoV-2 Vaccine, Compared with Intramuscular Covaxin® in Healthy Adults: A Randomised, Open-Label, Phase 3 Clinical Trial

Number of pages: 33 Posted: 31 Jan 2023
Chandramani Singh, Savita Verma, Prabhakar Reddy, Michael S. Diamond, David T. Curiel, Chintan Patel, Manish Kumar Jain, Sagar Vivek Redkar, Amit Suresh Bhate, Vivek Gundappa, Rambabu Konatham, Leelabati Toppo, Aniket Chandrakant Joshi, Jitendra Singh Kushwah, Ajit Pratap Singh, Shilpa Gaidhane, Krishna Mohan Vadrevu and BBV154 Study Group
All India Institute of Medical Sciences (AIIMS), Bhopal, Pt. B.D. Sharma Postgraduate Institute of Medical Sciences, Nizams Institute of Medical Sciences, Washington University School of Medicine - Department of Medicine, Washington University in St. Louis - Department of Radiation Oncology, Aatman Hospital, Maharaja Agrasen Super Speciality Hospital, Redkar Hospital and Research Centre, Jeevan Rekha Hospital, Rajarajeswari Medical College and Hospital, Visakha Institute of Medical Science, Malla Reddy Narayana Multispeciality Hospital, ONP Hospitals, Prakhar Hospital, Rana Hospital, Acharya Vinoba Bhave Rural Hospital, Bharat Biotech International Ltd and Independent
Downloads 1,517 (30,910)

Abstract:

Loading...

SARS-COV-2, COVID-19, vaccine, intranasal, intramuscular, immunogenicity, reactogenicity

2.

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Downloads 93 (444,808)

Selection of Optimum Formulation of RBD-Based Protein Sub-Unit Covid19 Vaccine (Corbevax) Based on Safety and Immunogenicity in an Open-Label, Randomized Phase-1 and 2 Clinical Studies

Number of pages: 48 Posted: 09 Mar 2022
Subhash Thuluva, Vikram Paradkar, Kishore Thuraga, Subbareddy Gunneri, Vijay Yerroju, Rammohanreddy Mogulla, Mahesh Kyasani, Senthilkumar Manoharan, Guruprasad Medigeshi, Janmejay Singh, Heena Shaman, Chandramani Singh and Venkateshwar Rao A
Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Biological E Limited, Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Vaccine and Infectious Disease Research Center, Government of India - Vaccine and Infectious Disease Research Center, All India Institute of Medical Sciences (AIIMS), Bhopal and St. Theresa s Hospital - Department of General Medicine
Downloads 93 (732,131)

Abstract:

Loading...

COVID-19, Vaccine, Receptor Binding Domain, SARS-CoV-2, Spike protein, Protein subunit

3.

The Impact of Indoor Residual Spraying on Sandfly Abundance and Incidence of Visceral Leishmaniasis in India from 2016 to 2022

Number of pages: 27 Posted: 14 Feb 2024
Luc E. Coffeng, Sake J De Vlas, Rudra Pratap Singh, Ananthu James, Joy Bindroo, Niteen K. Sharma, Asgar Ali, Chandramani Singh, Sadhana Sharma and Michael Coleman
Erasmus University Rotterdam (EUR) - Department of Public Health, Erasmus University Rotterdam (EUR) - Department of Public Health, Liverpool School of Tropical Medicine, Erasmus University Rotterdam (EUR) - Department of Public Health, CARE India, Liverpool School of Tropical Medicine, All India Institute of Medical Sciences (AIIMS), Bhopal, All India Institute of Medical Sciences (AIIMS), Bhopal, All India Institute of Medical Sciences (AIIMS), Bhopal and Liverpool School of Tropical Medicine
Downloads 119 (600,462)

Abstract:

Loading...

Kala-azar, vector ecology, entomology, vector control, vector surveillance